Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FSH Muscular Dystrophy”

79 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 79 results

Testing effectiveness (Phase 2)Ended earlyNCT04264442
What this trial is testing

Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE)

Who this might be right for
Facioscapulohumeral Muscular Dystrophy (FSHD)
Fulcrum Therapeutics 76
Not applicableUnknownNCT06086548
What this trial is testing

Unraveling Metabolic Involvement in Facioscapulohumeral Dystrophy Through Metabolomics

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
University Hospital, Angers 120
Testing effectiveness (Phase 2)Study completedNCT02531217
What this trial is testing

Safety, Tolerability, Pharmacokinetics (PK), and Activity of ATYR1940 in Participants With Muscular Dystrophy - Study Extension

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
aTyr Pharma, Inc. 9
Not applicableLooking for participantsNCT06363357
What this trial is testing

The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients With Neuromuscular Disorder

Who this might be right for
Muscular Dystrophy, DuchenneOrthotic DevicesUpper Extremity+6 more
Seoul National University Hospital 30
Not applicableStudy completedNCT02948244
What this trial is testing

Effect of Creatine Monohydrate on Functional Muscle Strength in Children With FSHD

Who this might be right for
Facio-Scapulo-Humeral DystrophyFSHD2FSHD1
Murdoch Childrens Research Institute 11
Testing effectiveness (Phase 2)Study completedNCT02239224
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Participants With Muscular Dystrophy

Who this might be right for
Facioscapulohumeral Muscular Dystrophy (FSHD)
aTyr Pharma, Inc. 20
Not applicableEnrolling By InvitationNCT07072676
What this trial is testing

The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

Who this might be right for
Inclusion Body MyositisMyotonic Dystrophy 1Myotonic Dystrophy 2+10 more
LMU Klinikum 30
Not applicableStudy completedNCT05178706
What this trial is testing

Effectiveness of Upper Extremity Rehabilitation in pwFSHD (Patient With Facioscapulohumeral Dystrophia)

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
Istanbul University - Cerrahpasa 36
Not applicableLooking for participantsNCT07409142
What this trial is testing

BetterLife FSHD: A Patient-driven Health and Research Platform

Who this might be right for
FSHFSH Muscular DystrophyFSHD - Facioscapulohumeral Muscular Dystrophy+8 more
FSHD Society 5,000
Testing effectiveness (Phase 2)Study completedNCT05747924
What this trial is testing

Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
FSHDFSHD1FSHD2+24 more
Avidity Biosciences, Inc. 90
Not applicableEnded earlyNCT06096441
What this trial is testing

FSHD Molecular Characterization

Who this might be right for
Facio-Scapulo-Humeral Dystrophy
Nationwide Children's Hospital 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT05548556
What this trial is testing

Evaluate RO7204239 in Participants With Facioscapulohumeral Muscular Dystrophy

Who this might be right for
Facioscapulohumeral Muscular Dystrophy (FSHD)
Hoffmann-La Roche 51
Not applicableLooking for participantsNCT05982119
What this trial is testing

Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study

Who this might be right for
Duchenne Muscular DystrophyFascioscapulohumeral Muscular DystrophyMyotonic Dystrophy 1+3 more
Centre Hospitalier Universitaire de Liege 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT06547216
What this trial is testing

Phase 2 Open-label Extension Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
FSHDFSHD1FSHD2+24 more
Avidity Biosciences, Inc. 84
Testing effectiveness (Phase 2)Ended earlyNCT03943290
What this trial is testing

Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Charcot-Marie Tooth (CMT) Disease Types 1 and X (CMT1 and CMTX)

Who this might be right for
Facioscapulohumeral Muscular DystrophyCharcot-Marie-Tooth Disease
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 62
Large-scale testing (Phase 3)Looking for participantsNCT07038200
What this trial is testing

Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD

Who this might be right for
Facioscapulohumeral Muscular DystrophyFSHDFSHD - Facioscapulohumeral Muscular Dystrophy+14 more
Avidity Biosciences, Inc. 200
Testing effectiveness (Phase 2)Looking for participantsNCT06907875
What this trial is testing

A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrophy

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
Epicrispr Biotechnologies, Inc. 12
Not applicableStudy completedNCT04907162
What this trial is testing

Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders

Who this might be right for
Pompe Disease (Late-onset)Myotonic Dystrophy Type 1 (DM1)Myotonic Dystrophy Type 2+4 more
LMU Klinikum 82
Not applicableLooking for participantsNCT06079567
What this trial is testing

An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease Progression

Who this might be right for
Facioscapulohumeral Muscular Dystrophy Type 2
Centre Hospitalier Universitaire de Nice 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT06222827
What this trial is testing

Study to Evaluate the Efficacy and Safety of Satralizumab in FSHD1

Who this might be right for
Facioscapulohumeral Muscular Dystrophy 1
Centre Hospitalier Universitaire de Nice 46
Load More Results